Metformin: what it does, what it's approved for, and what's hype
How this page is paid for: Some links here are partner links. If you start care through one, the provider may pay LongevityGLP1 a fee, and your monthly price stays the same. How we make money
The short answer
Metformin lowers blood sugar in type 2 diabetes, mainly by reducing the glucose your liver releases and helping your body use insulin. It is FDA-approved only for type 2 diabetes. People also take it off-label for prediabetes, weight or aging, but the trial evidence for those uses is weaker or, for aging, missing.
Definition
Metformin is a generic biguanide tablet, FDA-approved as an adjunct to diet and exercise to improve blood sugar control in type 2 diabetes. It has no FDA approval for weight loss, aging or longevity.
Key facts
| Fact | Detail |
|---|---|
| Drug class | Biguanide |
| FDA status | Approved; first brand (Glucophage, NDA 020357) approved March 3, 1995 and since discontinued; sold as generics[2] |
| Approved for | Type 2 diabetes: immediate-release tablets in adults and children 10 and older; extended-release in adults[1] |
| Not approved for | Weight loss, prediabetes, aging or longevity |
| Forms | Immediate-release tablets (500, 850, 1,000 mg); extended-release tablets (strengths vary by maker) |
| Boxed warning | Lactic acidosis |
| Online program price | $25–$162 a month |
| Prescription | Required |
Metformin is about as old and as ordinary as a prescription drug gets. It's a generic pill that has been sold in the US since 1995, and it's usually the first drug a person with type 2 diabetes is offered. It's also one of the drugs the longevity world talks about most. Off-label means a licensed prescriber can use it for something the FDA label doesn't cover, and every longevity use of metformin is off-label. The gap between those two reputations is what this page sorts out.
Metformin lowers the sugar your liver puts into your blood
Metformin's main job is to make your liver release less glucose. The label puts it in one sentence: metformin “decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization” [1].
- Your liver makes less new glucose, especially overnight, so fasting blood sugar drops.
- Your gut absorbs a little less glucose from food.
- Your muscles and other tissues take up and use more of the glucose in your blood, which is what “better insulin sensitivity” means.
- Your pancreas doesn't pump out extra insulin. The label says “insulin secretion remains unchanged.”
That last point is why metformin on its own rarely causes low blood sugar. Drugs that force the pancreas to release insulin can push blood sugar too low. Metformin doesn't work that way, though the label warns the risk rises when it's combined with insulin or a sulfonylurea.
Metformin is approved for type 2 diabetes, and nothing else
The US label approves metformin for one thing: improving blood sugar control in type 2 diabetes, alongside diet and exercise [1]. Everything else people use it for is off-label. Some of those uses rest on solid trials. Others rest on hope.
| Use | FDA status | Main evidence | What it showed |
|---|---|---|---|
| Type 2 diabetes | Approved | UKPDS 34 [7] | Fewer diabetes-related deaths and lower all-cause mortality vs conventional therapy in overweight adults |
| Preventing diabetes in prediabetes | Off-label | Diabetes Prevention Program [8] | 31% fewer new cases vs placebo; lifestyle change did better (58%) |
| Weight loss | Off-label | Label trials [1] | Small changes of a few pounds; in one 29-week trial, placebo lost slightly more |
| Aging and longevity | Off-label | No randomized trial; observational data only | Not shown; see metformin and longevity |
Off-label use is legal for a licensed prescriber, but FDA hasn't reviewed the drug for that purpose.
What is metformin used for other than diabetes? In the US, mostly the off-label uses above. Labels also differ by country. The UK's NHS lists using it to help prevent type 2 diabetes, in gestational diabetes, and for symptoms of polycystic ovary syndrome, which the NHS now calls polyendocrine metabolic ovarian syndrome [4]. The US label lists none of those.
The big trials show real benefits in diabetes and prediabetes
Two trials carry most of metformin's reputation. UKPDS 34 followed overweight adults with newly diagnosed type 2 diabetes for a median of about 10.7 years. Those who started on metformin had 32% fewer diabetes-related events, 42% fewer diabetes-related deaths and 36% lower all-cause mortality than those on conventional therapy [7]. In the Diabetes Prevention Program, metformin cut new diabetes by 31% in adults with prediabetes [8].
The DPP result has a second lesson that gets lost. The lifestyle program, aiming for 7% weight loss and 150 minutes of activity a week, beat metformin by a wide margin. To prevent one case of diabetes over three years, about 7 people had to do the lifestyle program, against about 14 taking metformin [8].
| Study | Design | Who | Finding |
|---|---|---|---|
| UKPDS 34 [7] | Randomized trial, about 10.7 years | 753 overweight adults with new type 2 diabetes (main comparison) | All-cause mortality 36% lower vs conventional therapy |
| Diabetes Prevention Program [8] | Randomized trial, mean 2.8 years | 3,234 adults with prediabetes, mean BMI 34 | Diabetes cut 31% on metformin, 58% with lifestyle change |
| Bannister 2014 [9] | Observational cohort | 78,241 people with type 2 diabetes on metformin vs 90,463 matched people without diabetes | Metformin users lived about as long or longer; can't prove cause |
| Konopka 2019 [10] | Randomized trial, 12 weeks | 53 older adults doing aerobic training | Metformin blunted gains in fitness and insulin sensitivity |
| MASTERS (Walton 2019) [11] | Randomized trial, 14 weeks | 94 healthy adults 65 and older doing strength training | Placebo gained more lean mass and thigh muscle than metformin |
Does metformin help you lose weight? A little, at most. The label's own trials show small weight changes: in one 29-week trial, people on metformin lost 1.4 pounds on average, and people on placebo lost 2.4 [1]. If weight is the main goal, GLP-1 drugs like semaglutide produce far larger losses, which is the point of our metformin vs Ozempic comparison.
Metformin for longevity: promising in theory, unproven in people
Metformin's longevity reputation comes mostly from one kind of evidence: observational studies of people with diabetes. In a large UK cohort, people with type 2 diabetes who started on metformin lived about as long as, or slightly longer than, matched people without diabetes [9]. That's interesting, but it can't separate the drug from the kind of people who get prescribed it.
No randomized trial has shown that metformin slows aging or extends life in people without diabetes. A trial called TAME was designed to test it [12], and no results have been published. Meanwhile, two trials in older adults found metformin blunted the benefits of exercise [10] [11]. For someone taking it to stay healthy, that's a real trade-off. The full story is on our metformin and longevity page, and rapamycin is the other off-label longevity drug people often weigh against it.
Stomach side effects are common; lactic acidosis is rare but serious
The most common metformin side effects are diarrhea, nausea or vomiting, gas, weakness, indigestion, abdominal discomfort and headache, each reported in more than 5% of people in the label's trials [1]. They tend to show up early. The extended-release form exists partly to make them easier to live with.
The boxed warning is lactic acidosis, a buildup of acid in the blood. It's rare, but the label says postmarketing cases have been fatal. Risk rises with kidney impairment, age 65 or older, contrast imaging, surgery, low oxygen, heavy drinking and liver impairment. Metformin is contraindicated when kidney function (eGFR) is below 30, and in metabolic acidosis [1].
| Warning | What the label says | What it means for you |
|---|---|---|
| Lactic acidosis (boxed) | Rare, can be fatal; risk rises with kidney or liver impairment, age 65+, contrast imaging, surgery | Your prescriber checks kidney function before and during treatment |
| Vitamin B12 deficiency | B12 fell to subnormal levels in about 7% of people in 29-week trials | Ask whether B12 should be checked, especially if you're tired or have numbness |
| Low blood sugar with other drugs | Risk rises with insulin or sulfonylureas | Doses of those drugs may need to come down |
| Heart outcomes | No study has established conclusive evidence of reduced large-vessel (macrovascular) risk | Metformin isn't a heart drug on its label |
From the metformin prescribing information on DailyMed.
Feeling run down on metformin is one of the most common questions people ask. Our guide to metformin and tiredness covers what the label lists, including the B12 link.
Some extended-release lots were recalled in 2020 for an impurity
In 2020 FDA found an impurity called NDMA above the acceptable intake limit in some extended-release metformin lots, and those lots were recalled. FDA said its testing had not found NDMA in immediate-release metformin [3]. FDA then asked extended-release makers to test every batch before release.
| Date | What happened |
|---|---|
| December 5, 2019 | FDA statement on NDMA found in some diabetes drugs outside the US |
| May 28, 2020 | FDA reported NDMA above the limit in certain extended-release lots and recommended recalls; no NDMA found in immediate-release |
| June 11, 2020 | FDA named five companies recalling extended-release lots and asked all extended-release makers to test each batch |
| January 6, 2021 | Last dated entry: one more extended-release lot recalled |
Source: FDA's metformin NDMA updates page. FDA said it could be dangerous for people with type 2 diabetes to stop metformin without first talking to their health care professional.
Metformin comes as immediate-release and extended-release tablets
Metformin comes in two forms. Immediate-release tablets come in 500, 850 and 1,000 mg. Extended-release tablets release the drug slowly and come in strengths that vary by maker [1]. Your prescriber chooses the form, the dose and when you take it, and the label adjusts the dose for kidney function.
What does a metformin pill look like? It depends on the maker. Generics come in different shapes and imprints, usually white to off-white. If a refill looks different from your last one, check the imprint with your pharmacist before you take it.
Metformin also comes inside combination pills
Metformin is often paired with a second diabetes drug in a single tablet. One example is Synjardy, which combines empagliflozin, the active ingredient in Jardiance, with metformin [6]. Jardiance on its own contains no metformin [5]. Combination pills carry the warnings of both drugs, so the metformin boxed warning applies to them too.
Some online weight programs also sell custom combinations that include metformin alongside other drugs. Those are different products with different evidence, and they aren't counted in the metformin prices below. If a program's “metformin” plan lists more than one ingredient, ask exactly what's in it and whether it's compounded.
Kidney function decides who can take metformin
Kidney function is the main gate. Metformin leaves the body through the kidneys, so the label rules it out below an eGFR of 30 and limits starting it when kidney function is already reduced [1]. It's also paused around iodinated contrast imaging in some people, and the label lists heavy drinking and liver impairment as risk factors for lactic acidosis.
Age matters too. The label counts age 65 and older as a lactic acidosis risk factor and advises more frequent kidney checks in older adults. None of that makes metformin a risky drug for most people with type 2 diabetes, but it's why a prescriber orders labs before writing it, even for an off-label goal.
What online programs charge for metformin
Metformin itself is a long-off-patent generic. Online programs that prescribe it charge $25–$162 a month, and that figure usually bundles the medication with a visit or a membership. Here's what each program charges.
| Provider | What the price covers | Monthly cost |
|---|---|---|
| BMIMDPartner | Generic metformin, month to month; a 3-month plan costs less per month | $55/mo |
| PeterMDPartner | Generic metformin, billed every 30 days | $60/mo |
| HealthRxPartner | Metformin plan, month to month; longer plans cost less per month | $134/mo |
| Found | Generics plan with medication and membership included | $162/mo |
Prices from each provider's own site and shown as a calendar-month cost, with required fees folded in. Combination products that contain metformin are not included.
If you already have a doctor, a prescription filled at a local pharmacy may cost less than any program above. Online programs mainly sell convenience and, for longevity use, a prescriber willing to consider it. Our monthly cost calculator helps compare a plan's billing with a pharmacy price, and the longevity prescription programs board scores the services.
Metformin is prescription-only, in person or online
Metformin isn't sold over the counter in the US; you need a prescription. A primary care doctor can prescribe it, and so can a telehealth clinician after an online visit. A prescriber will usually want recent kidney function and blood sugar results first. For the online route, read how to get a metformin prescription online.
Metformin and GLP-1 drugs are different, and often used together
Metformin and GLP-1 drugs like Ozempic work in different ways. Metformin mainly turns down the liver's glucose output. GLP-1 drugs act on gut-hormone receptors, slow stomach emptying and reduce appetite. Many people with type 2 diabetes take both, and the SURPASS-2 trial of Mounjaro enrolled people already on metformin. Our metformin vs Ozempic comparison walks through the differences.
Research on Metformin
Metformin side effects: how common diarrhea is, and what's rare but serious
Most metformin side effects live in the gut, and most of them fade. Here are the label's numbers for each one, the two things long-term users should watch, and the rare reaction that needs care right away.
Metformin and weight loss: about 2%, and why that's the honest number
Metformin is a diabetes drug with a small, steady effect on weight. Here's what the longest trial found, what the label's own trials showed, and how it compares with the GLP-1 drugs people usually mean when they ask.
Does metformin slow aging? The studies, read carefully
The case for metformin as an anti-aging drug rests on mice and on people with diabetes. Here is each study, what it can show, and the results that cut the other way.
How to get a metformin prescription online, and what to expect
Metformin is a decades-old generic, and plenty of online prescribers will consider it. Here's what they'll ask, which labs they'll want, and why longevity or weight use changes the conversation, plus what each route costs a month.
Metformin and tiredness: what's common, what's a warning sign
How often metformin causes weakness or headache, why long-term use can lower vitamin B12, and the rare kind of sleepiness that needs care right away.
Metformin compared
Compare providers
Providers that offer Metformin
- Bionomy Health review →
Bionomy Health
You want compounded semaglutide or tirzepatide without a subscription, would rather be charged only after a physician approves, and like knowing which pharmacy fills it.
- Nex Gen Health Rx review →
Nex Gen Health Rx
You want compounded semaglutide or tirzepatide at one price that doesn't climb with your dose, or a low-cost metformin prescription, and you like seeing every plan length priced before you buy.
- Hone Health review →
Hone Health
You want metformin for healthy aging with lab tracking built in, and you like having hormone and longevity care under one membership.
- PeterMD review →Visit site →
PeterMDPartner
You want generic metformin at a low printed price from a clinic that also handles testosterone, weight loss and lab testing in one place.
- iThriveMD review →
iThriveMD
You live in California or Arizona and want compounded semaglutide or tirzepatide with lab review, coaching and the option of in-person clinic visits.
See all 17 providers on the metformin and rapamycin lineup →
Frequently asked
- What is metformin used for besides diabetes?
- In the US, all other uses are off-label. The strongest evidence is for preventing diabetes in prediabetes (31% fewer cases in the Diabetes Prevention Program). Evidence for weight loss is weak, and no trial has shown it slows aging.
- Does metformin help you lose weight?
- Only a little, if at all. In the label's trials, weight changed by a few pounds, and in one 29-week trial placebo lost slightly more. Metformin isn't approved for weight loss.
- Is metformin over the counter?
- No. In the US, metformin needs a prescription. A doctor or a telehealth clinician can prescribe it, usually after checking kidney function.
- Does Jardiance have metformin in it?
- No. Jardiance contains empagliflozin, a different diabetes drug. A separate combination product, Synjardy, contains both empagliflozin and metformin.
- Is metformin safe long term?
- It has been used for decades, and the label supports long-term use in type 2 diabetes. The main long-term watch points are kidney function, which affects lactic acidosis risk, and vitamin B12 levels.
- Can metformin slow aging?
- That hasn't been shown in people. The evidence comes from observational studies of people with diabetes. The trial designed to test it, TAME, has no published results, and two trials found metformin blunted exercise gains in older adults.
Sources
- [1] Metformin hydrochloride tablets and extended-release tablets, prescribing information (2026). DailyMed label
- [2] Drugs@FDA: Glucophage, NDA 020357 (2026). FDA
- [3] FDA updates and press announcements on NDMA in metformin (2021). FDA
- [4] NHS: Metformin (2026). Source
- [5] Jardiance (empagliflozin) tablets, prescribing information (2026). DailyMed label
- [6] Synjardy (empagliflozin and metformin hydrochloride) tablets, prescribing information (2026). DailyMed label
- [7] UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group (1998). PMID 9742977
- [8] Knowler WC. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (2002). PMID 11832527
- [9] Bannister CA. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls (2014). PMID 25041462
- [10] Konopka AR. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults (2019). PMID 30548390
- [11] Walton RG. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double-blind, placebo-controlled, multicenter trial: The MASTERS trial (2019). PMID 31557380
- [12] Barzilai N. Metformin as a Tool to Target Aging (2016). PMID 27304507